2024 Q2 Form 10-Q Financial Statement

#000121465924009060 Filed on May 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $5.352M $5.759M $5.661M
YoY Change 0.32% 1.73% 3416.15%
Cost Of Revenue $3.262M $3.499M $3.907M
YoY Change -7.2% -10.44% 10181.58%
Gross Profit $2.090M $2.260M $1.754M
YoY Change 14.84% 28.85% 1326.02%
Gross Profit Margin 39.05% 39.24% 30.98%
Selling, General & Admin $1.104M $1.509M $3.250M
YoY Change -61.24% -53.57% 84.24%
% of Gross Profit 52.82% 66.77% 185.29%
Research & Development $5.000K $55.00K $8.000K
YoY Change -50.0% 587.5% -11.11%
% of Gross Profit 0.24% 2.43% 0.46%
Depreciation & Amortization $300.0K $299.0K $282.0K
YoY Change 16.28% 6.03% 705.71%
% of Gross Profit 14.35% 13.23% 16.08%
Operating Expenses $2.626M $2.907M $3.258M
YoY Change -8.12% -10.77% 84.69%
Operating Profit -$536.0K -$647.0K -$1.504M
YoY Change -48.36% -56.98% -8.35%
Interest Expense -$42.00K -$38.00K -$75.00K
YoY Change 162.5% -49.33% -129.64%
% of Operating Profit
Other Income/Expense, Net $190.0K $94.00K -$76.00K
YoY Change 21.79% -223.68% -2633.33%
Pretax Income -$346.0K -$553.0K -$1.580M
YoY Change -60.77% -65.0% 13.34%
Income Tax
% Of Pretax Income
Net Earnings -$346.0K -$553.0K -$1.580M
YoY Change -60.77% -65.0% 13.34%
Net Earnings / Revenue -6.46% -9.6% -27.91%
Basic Earnings Per Share -$0.03 -$0.05 -$0.17
Diluted Earnings Per Share -$0.03 -$0.05 -$0.17
COMMON SHARES
Basic Shares Outstanding 10.18M shares 10.14M shares 9.362M shares
Diluted Shares Outstanding 10.24M shares 10.07M shares 9.333M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.900M $2.818M $3.085M
YoY Change 7.53% -8.65% -64.03%
Cash & Equivalents $2.900M $2.755M $3.085M
Short-Term Investments
Other Short-Term Assets $210.0K $261.0K $367.0K
YoY Change -31.82% -28.88% 46.8%
Inventory $23.00K $32.00K $54.00K
Prepaid Expenses
Receivables $1.214M $1.197M $1.703M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $5.098M $5.224M $5.906M
YoY Change 0.51% -11.55% -34.77%
LONG-TERM ASSETS
Property, Plant & Equipment $184.0K $212.0K $292.0K
YoY Change -36.11% -27.4% 55.32%
Goodwill $5.334M $5.309M $1.383M
YoY Change -0.07% 283.88%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $160.0K
YoY Change
Total Long-Term Assets $12.44M $12.67M $13.51M
YoY Change -6.87% -6.19% 13.83%
TOTAL ASSETS
Total Short-Term Assets $5.098M $5.224M $5.906M
Total Long-Term Assets $12.44M $12.67M $13.51M
Total Assets $17.53M $17.89M $19.41M
YoY Change -4.84% -7.82% -7.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.331M $1.214M $1.578M
YoY Change -4.93% -23.07% 159.11%
Accrued Expenses $808.0K $716.0K $891.0K
YoY Change 11.76% -19.64%
Deferred Revenue
YoY Change
Short-Term Debt $500.0K $500.0K $500.0K
YoY Change 0.0% 0.0%
Long-Term Debt Due $500.0K $500.0K $1.000M
YoY Change -61.54% -50.0%
Total Short-Term Liabilities $2.927M $2.792M $3.809M
YoY Change -21.3% -26.7% 525.45%
LONG-TERM LIABILITIES
Long-Term Debt $1.725M $1.850M $1.250M
YoY Change 53.33% 48.0%
Other Long-Term Liabilities $624.0K $860.0K $1.390M
YoY Change -48.94% -38.13% 1003.17%
Total Long-Term Liabilities $2.349M $2.710M $2.640M
YoY Change 0.09% 2.65% 1995.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.927M $2.792M $3.809M
Total Long-Term Liabilities $2.349M $2.710M $2.640M
Total Liabilities $5.276M $5.502M $6.449M
YoY Change -13.02% -14.68% 777.41%
SHAREHOLDERS EQUITY
Retained Earnings -$82.75M -$82.40M -$80.04M
YoY Change 2.26% 2.95%
Common Stock $11.00K $10.00K $10.00K
YoY Change 10.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $464.0K $589.0K $793.0K
YoY Change -41.41% -25.73%
Treasury Stock Shares
Shareholders Equity $12.26M $12.39M $12.96M
YoY Change
Total Liabilities & Shareholders Equity $17.53M $17.89M $19.41M
YoY Change -4.84% -7.82% -7.2%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$346.0K -$553.0K -$1.580M
YoY Change -60.77% -65.0% 13.34%
Depreciation, Depletion And Amortization $300.0K $299.0K $282.0K
YoY Change 16.28% 6.03% 705.71%
Cash From Operating Activities $372.0K -$60.00K -$126.0K
YoY Change -210.39% -52.38% -87.41%
INVESTING ACTIVITIES
Capital Expenditures $81.00K $2.000K $13.00K
YoY Change -62.67% -84.62% -154.17%
Acquisitions $363.0K
YoY Change
Other Investing Activities $0.00 -$399.0K
YoY Change -100.0%
Cash From Investing Activities -$81.00K -$110.0K -$621.0K
YoY Change -65.82% -82.29% 2487.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -207.0K -$106.0K $423.0K
YoY Change -211.89% -125.06% 1075.0%
NET CHANGE
Cash From Operating Activities 372.0K -$60.00K -$126.0K
Cash From Investing Activities -81.00K -$110.0K -$621.0K
Cash From Financing Activities -207.0K -$106.0K $423.0K
Net Change In Cash 84.00K -$277.0K -$326.0K
YoY Change -121.59% -15.03% -67.04%
FREE CASH FLOW
Cash From Operating Activities $372.0K -$60.00K -$126.0K
Capital Expenditures $81.00K $2.000K $13.00K
Free Cash Flow $291.0K -$62.00K -$139.0K
YoY Change -152.53% -55.4% -85.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1121000 usd
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
usd
CY2023Q1 us-gaap Asset Acquisition Consideration Transferred Contingent Consideration
AssetAcquisitionConsiderationTransferredContingentConsideration
usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
usd
CY2023Q1 vrme Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
usd
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
usd
CY2024Q1 vrme Deferred Implementation Costs
DeferredImplementationCosts
usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
CY2024Q1 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
shares
CY2024Q1 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice
CY2024Q1 vrme Sharebased Compensation Arrangement By Sharebased Payment Award Other Than Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1
usd
CY2024Q1 vrme Rightofuse Assets Obtained In Exchange For Operating Lease Liabilities
RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities
usd
CY2023Q4 vrme Rightofuse Assets Obtained In Exchange For Operating Lease Liabilities
RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities
usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
usd
CY2024Q1 vrme Contingent Liability Non Current
ContingentLiabilityNonCurrent
597000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
2260000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
1521000 usd
CY2024Q1 us-gaap Management Fee Expense
ManagementFeeExpense
1343000 usd
CY2023Q1 us-gaap Management Fee Expense
ManagementFeeExpense
1105000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1413000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
388000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
499000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
2907000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
3025000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-647000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1504000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-38000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-42000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-32000 usd
CY2024Q1 us-gaap Asset Acquisition Consideration Transferred Contingent Consideration
AssetAcquisitionConsiderationTransferredContingentConsideration
132000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
94000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-76000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-553000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1580000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10073445 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9332553 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10073445 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9332553 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-553000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1580000 usd
CY2024Q1 vrme Change In Fair Value Of Interest Rate Swap
ChangeInFairValueOfInterestRateSwap
3000 usd
CY2023Q1 vrme Change In Fair Value Of Interest Rate Swap
ChangeInFairValueOfInterestRateSwap
-1000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
67000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
2000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-617000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1583000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
10000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3000 usd
CY2024Q1 us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
46000 usd
CY2023Q1 us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
22000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-32000 usd
CY2024Q1 vrme Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
132000 usd
CY2024Q1 vrme Fair Value Of Restricted Stock Awards And Restricted Stock Units Issued In Exchange For Services
FairValueOfRestrictedStockAwardsAndRestrictedStockUnitsIssuedInExchangeForServices
-412000 usd
CY2023Q1 vrme Fair Value Of Restricted Stock Awards And Restricted Stock Units Issued In Exchange For Services
FairValueOfRestrictedStockAwardsAndRestrictedStockUnitsIssuedInExchangeForServices
-264000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-2000 usd
CY2024Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
4000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
299000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
282000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-53000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1804000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2742000 usd
CY2024Q1 vrme Oprating Unbilled Revenue
OpratingUnbilledRevenue
363000 usd
CY2023Q1 vrme Oprating Unbilled Revenue
OpratingUnbilledRevenue
488000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-7000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-27000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
42000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2365000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2366000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-60000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-126000 usd
CY2024Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
11000 usd
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
31000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
363000 usd
CY2023Q1 vrme Deferred Implementation Costs
DeferredImplementationCosts
36000 usd
CY2024Q1 us-gaap Payments For Software
PaymentsForSoftware
97000 usd
CY2023Q1 us-gaap Payments For Software
PaymentsForSoftware
178000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-110000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-621000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
500000 usd
CY2024Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
21000 usd
CY2023Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
59000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
1000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
10000 usd
CY2024Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
125000 usd
CY2023Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
125000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-106000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
423000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-277000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-326000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3095000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3411000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2818000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3085000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
70000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
34000 usd
CY2024Q1 vrme Noncash Change In Fair Value Of Interest Rate Swap
NoncashChangeInFairValueOfInterestRateSwap
3000 usd
CY2023Q1 vrme Noncash Change In Fair Value Of Interest Rate Swap
NoncashChangeInFairValueOfInterestRateSwap
1000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
13586000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000 usd
CY2023Q1 vrme Restricted Stock Units Net Of Shares Withheld For Employee Tax
RestrictedStockUnitsNetOfSharesWithheldForEmployeeTax
262000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
81000 usd
CY2023Q1 vrme Common Stock Issued In Relation To Acquisition
CommonStockIssuedInRelationToAcquisition
625000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1580000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
12962000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
12531000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
148000 usd
CY2024Q1 vrme Restricted Stock Units Net Of Shares Withheld For Employee Tax
RestrictedStockUnitsNetOfSharesWithheldForEmployeeTax
263000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
25000 usd
CY2024Q1 vrme Common Stock Issued In Relation To Acquisition
CommonStockIssuedInRelationToAcquisition
42000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-64000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-553000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
12391000 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zwjwTSfPpIyh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i><span style="text-decoration: underline"><span id="xdx_867_zFYQATE7JZhj">Reclassifications</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Certain amounts presented for the three months ended March 31, 2023, reflect reclassifications made to conform to the presentation in our current reporting period. These reclassifications had no effect on the previously reported net loss.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q1 us-gaap Goodwill Gross
GoodwillGross
5309000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2755000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3032000 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
63000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
63000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2818000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3095000 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
63000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
63000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss After Tax
ForeignCurrencyTransactionGainLossAfterTax
62000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss After Tax
ForeignCurrencyTransactionGainLossAfterTax
0 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zCvCXlN5oag4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_86B_zsa3aa1h5kda">Use of Estimates</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p>
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8383000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6139000 shares
CY2024Q1 us-gaap Revenues
Revenues
5759000 usd
CY2023Q1 us-gaap Revenues
Revenues
5661000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1282000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1185000 usd
CY2024Q1 vrme Contract Asset Additions
ContractAssetAdditions
916000 usd
CY2023Q1 vrme Contract Asset Additions
ContractAssetAdditions
697000 usd
CY2024Q1 vrme Reclassification To Accounts Receivable Billed To Customers
ReclassificationToAccountsReceivableBilledToCustomers
-1282000 usd
CY2023Q1 vrme Reclassification To Accounts Receivable Billed To Customers
ReclassificationToAccountsReceivableBilledToCustomers
-1185000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
916000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
697000 usd
CY2023Q1 vrme Business Combination Consideration Transferred
BusinessCombinationConsiderationTransferred
360000 usd
CY2023Q1 vrme Earnout Consideration
EarnoutConsideration
1100000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
195000 usd
CY2023Q1 vrme Business Combination Long Term Contingent Consideration
BusinessCombinationLongTermContingentConsideration
597000 usd
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
5384000 usd
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-75000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8843000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-2114000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6729000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9006000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-2079000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6927000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
269000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
240000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
858000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1100000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1096000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1062000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
687000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1926000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6729000 usd
CY2024Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
148000 usd
CY2023Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
1000 usd
CY2024Q1 vrme Stock Issued During Period Value Restricted Stock Award Net
StockIssuedDuringPeriodValueRestrictedStockAwardNet
264000 usd
CY2023Q1 vrme Stock Issued During Period Value Restricted Stock Award Net
StockIssuedDuringPeriodValueRestrictedStockAwardNet
263000 usd
CY2024Q1 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
1750 shares
CY2024Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
30000 shares
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
42000 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
308462 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
329351 shares
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
589000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
659000 usd
CY2023Q4 us-gaap Accelerated Share Repurchases Adjustment To Recorded Amount
AcceleratedShareRepurchasesAdjustmentToRecordedAmount
500000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1000 shares
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
1000 usd
CY2024Q1 vrme Unrecognized Compensation Cost Outstanding
UnrecognizedCompensationCostOutstanding
0 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
4628586 shares
CY2023Q4 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice
4.13
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
4628586 shares
CY2024Q1 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice
4.13
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P2Y
CY2024Q1 vrme Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
4628586 shares
CY2024Q1 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice
4.13
CY2024Q1 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Exercisable Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingExercisableWeightedAverageRemainingContractualTerms
P2Y
CY2024Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
500000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
800000 usd
CY2024Q1 vrme Principal Outstanding
PrincipalOutstanding
125000 usd
CY2024Q1 us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
0 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1958000 usd
CY2022Q4 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.07602 pure
CY2023Q3 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
1100000 usd
CY2023Q3 vrme Convertiable Promissory Notes Purchased By Related Party
ConvertiablePromissoryNotesPurchasedByRelatedParty
475000 usd
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
22000 usd
CY2024Q1 us-gaap Convertible Debt
ConvertibleDebt
1100000 usd
CY2024Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
0 usd
CY2023Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
0 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
47000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
37000 usd
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
5000 usd
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
9000 usd
CY2024Q1 us-gaap Lease Cost
LeaseCost
52000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
46000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
419000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
468000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
167000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
170000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
263000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
307000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
430000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
477000 usd
CY2024Q1 vrme Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities
46000 usd
CY2023Q4 vrme Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities
177000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M18D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.064 pure
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
142000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
192000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
139000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
45000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
518000 usd
CY2024Q1 us-gaap Receivable With Imputed Interest Net Amount
ReceivableWithImputedInterestNetAmount
88000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
430000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
167000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
263000 usd
CY2024Q1 us-gaap Revenues
Revenues
5759000 usd
CY2023Q1 us-gaap Revenues
Revenues
5661000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
2260000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
1521000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1121000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1413000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-647000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1504000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
94000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-76000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-553000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1580000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001214659-24-009060-index-headers.html Edgar Link pending
0001214659-24-009060-index.html Edgar Link pending
0001214659-24-009060.txt Edgar Link pending
0001214659-24-009060-xbrl.zip Edgar Link pending
ex10_1.htm Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v5324010q.htm Edgar Link pending
vrme-20240331.xsd Edgar Link pending
vrme_bluelogo.jpg Edgar Link pending
vrme-20240331_cal.xml Edgar Link unprocessable
vrme-20240331_def.xml Edgar Link unprocessable
vrme-20240331_lab.xml Edgar Link unprocessable
vrme-20240331_pre.xml Edgar Link unprocessable
v5324010q_htm.xml Edgar Link completed